Concepedia

Deborra Mullins

DM

Statistics

Publications

31

Citations

1.4K

H-Index

22

Active since

1980

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

New York University

University of Cincinnati

AGCO (United Kingdom)

Deborra Mullins is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and neuropharmacology.

Publications per year

1980–2015

31

Publications

31

The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents

P.H. Hutson, Eleftheria N. Finger, Brian C. Magliaro et al. · Neuropharmacology · 2011 · 139 citations

, , +16

GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists

Eric M. Parker, Carol K Babij, Ambikaipakan Balasubramaniam et al. · European Journal of Pharmacology · 1998 · 115 citations

, , +14

Activation of the NPY Y5 receptor regulates both feeding and energy expenditure

Joyce Hwa, Melanie B. Witten, Patricia A.M. Williams et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 1999 · 104 citations

, , +17

Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.

JL Gross, D L Behrens, Deborra Mullins et al. · PubMed · 1988 · 93 citations

, , +12

[D-Trp34] neuropeptide Y is a potent and selective neuropeptide Y Y5 receptor agonist with dramatic effects on food intake☆

Eric M. Parker, Ambikaipakan Balasubramaniam, M. Guzzi et al. · Peptides · 2000 · 85 citations

, , +11

1–5 of 31